Abstract | BACKGROUND:
Arthropod-borne viral encephalitis of diverse origins shows similar clinical symptoms, histopathology and magnetic resonance imaging, indicating that the patho mechanisms may be similar. There is no specific therapy to date. However, vaccination remains the best prophylaxis against a selected few. Regardless of these shortcomings, there are an increasing number of case reports that successfully treat arboviral encephalitis with high doses of intravenous immunoglobulins. DISCUSSION: SUMMARY:
|
Authors | Daniel Růžek, Gerhard Dobler, Hans Helmut Niller |
Journal | BMC infectious diseases
(BMC Infect Dis)
Vol. 13
Pg. 306
(Jul 03 2013)
ISSN: 1471-2334 [Electronic] England |
PMID | 23822550
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Immunoglobulins, Intravenous
|
Topics |
- Antibodies, Viral
(administration & dosage, adverse effects, immunology)
- Encephalitis, Tick-Borne
(immunology, therapy, virology)
- Humans
- Immunoglobulins, Intravenous
(administration & dosage, adverse effects, immunology)
- Male
- Middle Aged
|